RARITAN, N.J., Oct. 19, 2016 /PRNewswire/ -- Ortho Clinical
Diagnostics (Ortho), a global leader of in vitro diagnostics, today
announced it will present two scientific posters on its automated
immunohematology instruments and showcase three next-generation
automation products at its booth (No. 1001) at the 2016 AABB Annual
Meeting. Ortho will also host a customer event that will feature
presentations by local hospital blood bank, laboratory and
transfusion services managers, including two from Orlando Regional
Medical Center, who will discuss the hospital's mass transfusion
protocol in the aftermath of the nightclub attack in June 2016. The conference will be held
October 22-25 in Orlando's Orange
County Convention Center.
"As the world leader in immunohematology, we are committed to
empowering transfusion medicine laboratories with product solutions
and information that help to improve processes and meet increased
pressures on blood banks," said Heidi Casaletto, head of
transfusion medicine for Ortho. "We welcome this opportunity to
present our research and demonstrate to the industry what's
possible in the laboratory through our workshops and ORTHO
VISION® platform."
Ortho and its customers will share the following poster
presentations:
- A Multicenter Evaluation Comparing a New Automated
Immunohematology Instrument with the ORTHO ProVue®
- Author Presentation: October 23,
2016
- Presenters: Agnes Aysola, M.D.,
Leslie Wheeler, Richard Brown, M.D., Rebecca Denham, Connie
Colavecchia, Katerina
Pavenski, M.D., Elizabeth
Krok, Chelsea Hayes, M.D.,
Ellen Klapper, M.D.
- Multi-Site Evaluation for Performance of a Platform Based
Fully Automated Immunohematology (IH) Instrument
- Author Presentation: October 23,
2016
- Presenter: Tony Casina, Ortho
Clinical Diagnostics
The company will also host an invitation-only customer event on
Sunday, October 23, at 6:30 p.m., featuring sessions on mass transfusion
protocol and testing in transfusion services. The featured speakers
will include:
- Massive Transfusion Protocols (MTP) Theory and
Practice: Lourdes Miller,
blood bank supervisor at Orlando Regional Medical Center, and
Carol Fortier, laboratory manager at
Dr. P. Phillips Hospital, will discuss the Orlando Health
Hospitals' response to the mass shooting at Pulse nightclub in
June. Orlando Regional Medical Center is the main hospital of
Orlando Health, Inc., a not-for-profit healthcare network serving
Central Florida. Representatives
will discuss how they planned for, practiced and ultimately
executed their massive transfusion protocol in the wake of the
tragic event.
- Health System Standardization Decisions in the Blood
Bank: Diana Ramirez-Gomez,
manager of transfusion services, and Morgan
Lenhart, assistant manager of transfusion services, both of
Florida Hospital, will discuss how the facility's laboratory has
handled challenges in methodology. Hospital managers faced a
system-wide decision to standardize processes, while reducing
costs.
Another highlight of Ortho's presence at the AABB Annual Meeting
will be an industry workshop in partnership with Quotient on
Monday, October 24 at 7:00 a.m., entitled, "Challenges and
Opportunities to Better Match Donor Units with Patients to Reduce
Alloimmunization Risks and Efficiently Improve Patient Care".
Speakers at this workshop will address the increasing role of
personalized medicine in immunohematology as it relates to better
matching of donor units to patients. Dr. Gregory Denomme, senior director of
immunohematology and innovation for Versiti blood centers, Dr.
Aaron Tobian, associate professor of
pathology, medicine and epidemiology of Johns
Hopkins University School of Medicine and Dr. Silvano Wendel, medical director of Hospital
Sirio Libanes Blood Bank in São Paulo, Brazil, will share examples of how they have
implemented personalized medicine in patient-matching and advances
in donor identification with the goal of mitigating
alloimmunization. Topics will include limitations of current
practices; potential changes in practice with an eye toward future
standards of care; and the health economic impact.
Products showcased in Ortho's booth (No. 1001) will include the
ORTHO VISION® and ORTHO VISION® Max*
analyzers. Part of the integrated, comprehensive product suite of
the ORTHO VISION platform, the fully automated analyzers improve
workflow and standardize systems and processes in transfusion
laboratories. Also displayed at the booth will be the ORTHO™
Workstation, the only compact 2-in-1 blood testing system with
reliable ID-Micro Typing System™ (ID-MTS™) Gel Column Agglutination
Technology (CAT).
*Pending 510(k) clearance
About Ortho Clinical Diagnostics
Ortho Clinical
Diagnostics is a global leader of in vitro diagnostics serving the
clinical laboratory and immunohematology communities. Across
hospitals, hospital networks, blood banks and labs in more than 120
countries, Ortho's high-quality products and services enable health
care professionals to make better-informed treatment decisions. For
the immunohematology community, Ortho's blood typing products help
ensure every patient receives blood that is safe, the right type
and the right unit. Ortho brings sophisticated testing
technologies, automation, information management and interpretation
tools to clinical laboratories around the world to help them run
more efficiently and effectively and improve patient care. Ortho's
purpose is to improve and save lives with diagnostics, and it does
that by reimagining what's possible. This is what has defined Ortho
for more than 75 years, and it's what drives Ortho forward. For
more information, visit www.orthoclinicaldiagnostics.com.
© Ortho Clinical Diagnostics 2016
Logo - http://photos.prnewswire.com/prnh/20161019/430310LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ortho-clinical-diagnostics-to-present-data-on-automation-in-immunohematology-three-products-at-2016-aabb-annual-meeting-300347557.html
SOURCE Ortho Clinical Diagnostics